EuropaBio Advanced Therapies webinar on EU case for equitable patient access to advanced therapies

EuropaBio continues its Advanced Therapies webinar series of events, interviews, and publications with a virtual discussion on avenues for enhancing the access of EU patients to novel biotechnology-derived treatments titled “Treatment without borders: the EU case for equitable patient access to advanced therapies.”

The webinar will take place on September 7, 2021 from 16.00 – 17.00 CET.

The event will address whether EU cross-border access to advanced treatments is a reality or a goal for the future and the value of treatments for rare disease patients, followed by a presentation on gene therapies and their value for rare disease patients. The panel includes:

  • Martin Dorazil, Deputy Head of Unit Digital Health, DG Health, European Commission
  • Brieuc Van Damme, Director-General Healthcare, RIZIV-INAMI
  • Dirk Vander Mijnsbrugge, Vice President Medical Affairs Lead Rare Diseases International Developed Markets, Pfizer
  • Irina Grossenbacher, Region Europe Patient Access Director, Novartis Rare Diseases
  • Tomislav Sokol, Menmber of the European Parliament, EPP, Croatia

More information and registration here: